Amgen (AMGN) Net Margin (QoQ) (2009 - 2026)
Amgen (AMGN) Net Margin (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.19 Bn | 631.43 Bn | 17.26 Bn |
| 2 | AbbVie | 470.70 Bn | 464.13 Bn | 12.70 Bn |
| 3 | Merck | 379.55 Bn | 372.41 Bn | 12.21 Bn |
| 4 | Novartis Ag | 302.93 Bn | 295.24 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.73 Bn | 252.83 Bn | 12.86 Bn |
| 6 | Amgen | 236.90 Bn | 222.91 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 182.87 Bn | 179.69 Bn | 6.22 Bn |
| 8 | Pfizer | 161.71 Bn | 150.01 Bn | 10.94 Bn |
| 9 | Gsk | 105.60 Bn | 101.43 Bn | 8.24 Bn |
| 10 | Sanofi | 55.13 Bn | 47.75 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 252.00 |
| Mar 31, 2026 | 760.00 |
| Dec 31, 2025 | -2,014.00 |
| Sep 30, 2025 | 1,805.00 |
| Jun 30, 2025 | -563.00 |
| Mar 31, 2025 | 1,433.00 |
| Dec 31, 2024 | -2,638.00 |
| Sep 30, 2024 | 2,439.00 |
| Jun 30, 2024 | 1,041.00 |
| Mar 31, 2024 | -1,088.00 |
| Dec 31, 2023 | -1,570.00 |
| Sep 30, 2023 | 532.00 |
| Jun 30, 2023 | -2,680.00 |
| Mar 31, 2023 | -30,553.00 |
| Dec 31, 2022 | 31,985.00 |
| Sep 30, 2022 | 1,224.00 |
| Jun 30, 2022 | -369.00 |
| Mar 31, 2022 | -408.00 |
| Dec 31, 2021 | -36.00 |
| Sep 30, 2021 | 2,098.00 |